Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet beta cells.

Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet beta cells.
复制标题

DOI:
10.1172/jci20016
复制
发表时间:
2004-10
期刊:
The Journal of clinical investigation
影响因子:
--
通讯作者:
E. Bernal-Mizrachi;S. Fátrai;James D. Johnson;M. Ohsugi;K. Otani;Zhi-qiang Han;K. Polonsky;M. Permutt
E. Bernal-Mizrachi;S. Fátrai;James D. Johnson;M. Ohsugi;K. Otani;Zhi-qiang Han;K. Polonsky;M. Permutt
中科院分区:
其他
文献类型:
--
作者:
E. Bernal-Mizrachi;S. Fátrai;James D. Johnson;M. Ohsugi;K. Otani;Zhi-qiang Han;K. Polonsky;M. Permutt

文献摘要

被引文献

相似文献

胰岛素和 IGF 信号通路对于胰腺 β 细胞质量和功能的发育和维持至关重要。丝氨酸-苏氨酸激酶 Akt 是受这些途径调节的几种介质之一。我们通过在β细胞中表达该酶的激酶死亡突变体的转基因小鼠,研究了Akt在胰腺β细胞生理学中的作用。转基因动物中 Akt 活性的降低会因胰岛素分泌缺陷而导致葡萄糖耐量受损。这些小鼠分泌失调的机制在于胰岛素胞吐作用水平,而不是葡萄糖信号传导或电压门控 Ca2+ 通道功能异常的结果。因此,转基因小鼠在脂肪喂养后表现出对葡萄糖不耐受和糖尿病的易感性增加。这些观察结果表明,Akt 在分泌途径远端成分的调节中发挥着新颖且重要的作用,并且该酶代表了改善糖尿病中 β 细胞功能的治疗靶点。
The insulin and IGF signaling pathways are critical for development and maintenance of pancreatic beta cell mass and function. The serine-threonine kinase Akt is one of several mediators regulated by these pathways. We have studied the role of Akt in pancreatic beta cell physiology by generating transgenic mice expressing a kinase-dead mutant of this enzyme in beta cells. Reduction of Akt activity in transgenic animals resulted in impaired glucose tolerance due to defective insulin secretion. The mechanisms involved in dysregulation of secretion in these mice lie at the level of insulin exocytosis and are not the result of abnormalities in glucose signaling or function of voltage-gated Ca2+ channels. Therefore, transgenic mice showed increased susceptibility to developing glucose intolerance and diabetes following fat feeding. These observations suggest that Akt plays a novel and important role in the regulation of distal components of the secretory pathway and that this enzyme represents a therapeutic target for improvement of beta cell function in diabetes.